TY - GEN 
AU - Rincon Valenzuela, David; Gomez Ardila, Ciro
PY - 2020
SN - 0034-8244
UR - http://hdl.handle.net/10818/51064
AB - Introduction: Malignant hyperthermia is an acute syndrome
triggered by certain anesthetic medications. Dantrolene is the
only specific treatment for malignant hyperthermia crises.
Without treatment, lethalitymay be as high as 80%. In Colombia,
it is...
AB - Introduccion:   La hipertermia maligna (HM) es un sindrome agudo
desencadenado por algunos medicamentos anestesicos. El
dantroleno es el unico tratamiento especi   fico para las crisis de
HM. Sin tratamiento puede tener una letalidad cercana al 80%....
LA - eng
PB - Colombian Journal of Anestesiology
KW - Anesthesia
KW - Malignant Hyperthermia
KW - Dantrolene
KW - Economics
KW - Hospital
KW - Economics
KW - Pharmaceutical
KW - Decision Making
KW - Organizational
KW - Anestesia
KW - Hipertermia maligna
KW - Dantroleno
KW - Economia Hospitalaria
KW - Farmacoeconomia
KW - Toma de decisiones en la organizacion
TI - Cost–benefit relationship of keeping dantrolene
stocks from the point of view of healthcare
institutions
DO - Rincón-Valenzuela, D. A., & Gómez-Ardila, C. (2020). Cost-benefit relationship of keeping dantrolene stocks from the point of view of healthcare institutions. Colombian Journal of Anestesiology, 48(2), 63-70.
ER -